Free Trial

Mizuho's Rating of Axsome Therapeutics on 11/4/2026

On November 4, 2026, Mizuho updated its outlook on Axsome Therapeutics (NASDAQ:AXSM) with the action "Lower Price Target", setting a price target of $272.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Mizuho

DateCompanyAction
11/4/2026
The Mosaic Company stock logo
MOS
Mosaic
Set Price Target
11/4/2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
Set Price Target
11/4/2026
Red Rock Resorts, Inc. stock logo
RRR
Red Rock Resorts
Set Price Target
11/4/2026
Coupang, Inc. stock logo
CPNG
Coupang
Set Price Target
11/4/2026
CarMax, Inc. stock logo
KMX
CarMax
Set Price Target
11/4/2026
Booking Holdings Inc. stock logo
BKNG
Booking
Set Price Target
More Ratings From Mizuho